Legrand Y, Karniguian A, Fauvel F
Nouv Rev Fr Hematol (1978). 1981;23(3):143-8.
This review deals with some structural features of the collagen molecules involved in the adhesion of platelets representing the initial step of hemostasis, thrombosis, and (partly) atherosclerosis. The adhesion occurs at the level of a vascular lesion or deendothelialized area, whatever the genetic type of collagen. In vitro experiments with purified collagens have shown that vascular interstitial collagens (types I and III, the latter present in subendothelium) as well as basement membrane-derived collagens (types IV and V) induce an adhesion of platelets, provided that an ordered arrangement linked to the quaternary and tertiary structures of their molecule is preserved. Whatever the quaternary structure, the important point seems to be the size of the fibers and more precisely the availability of an optimal number of adhesion sites on multimerized fibers. Various direct or indirect proofs (for example, the occurrence of the impairment of collagen multimerization on platelet adhesion/aggregation) are reviewed. Our recent studies on interstitial collagens have shown the involvement of certain specific amino-acid sequences obtained after cyanogen bromide cleavage of collagen. These are the C-terminal alpha1 (I) CB6 peptide of the alpha 1 chains of type I collagen (216 amino acids) and the central alpha1 (III) CB4 peptide from type III collagen (149 amino acids) Cleavage of this last peptide by chymotrypsin, hydroxylamine, and trypsin has suggested the possibility that a nonapeptide (sequence gly-lys-hyp-gly-glu-hyp-gly-pro-lys) is a minimum site of adhesion for platelets. This assumption has been reinforced by the fact that a synthetic nonapeptide with this sequence specifically inhibits the aggregation of platelets to collagen in vitro. The adhesion of platelets may consequently be due to the repetitive staggering of short amino acid sequences (such as this nonapeptide from type III collagen) along the rigid structure formed by a multimerized collagen fiber.
本综述探讨了胶原蛋白分子的一些结构特征,这些特征与血小板黏附有关,而血小板黏附是止血、血栓形成及(部分)动脉粥样硬化的起始步骤。无论胶原蛋白的基因类型如何,黏附均发生在血管损伤或内皮剥脱区域水平。对纯化胶原蛋白的体外实验表明,血管间质胶原蛋白(I型和III型,后者存在于内皮下)以及基底膜衍生的胶原蛋白(IV型和V型)均可诱导血小板黏附,前提是与其分子的四级和三级结构相关的有序排列得以保留。无论四级结构如何,关键似乎在于纤维的大小,更确切地说是多聚化纤维上最佳数量黏附位点的可用性。本文综述了各种直接或间接证据(例如,胶原蛋白多聚化受损对血小板黏附/聚集的影响)。我们最近对间质胶原蛋白的研究表明,胶原蛋白经溴化氰裂解后获得的某些特定氨基酸序列参与其中。这些序列包括I型胶原蛋白α1链的C末端α1(I)CB6肽(216个氨基酸)和III型胶原蛋白的中央α1(III)CB4肽(149个氨基酸)。胰凝乳蛋白酶、羟胺和胰蛋白酶对最后一种肽的裂解表明,九肽(序列为甘氨酸-赖氨酸-羟脯氨酸-甘氨酸-谷氨酸-羟脯氨酸-甘氨酸-脯氨酸-赖氨酸)可能是血小板的最小黏附位点。这一假设因以下事实而得到加强:具有该序列的合成九肽在体外可特异性抑制血小板与胶原蛋白的聚集。因此,血小板的黏附可能是由于短氨基酸序列(如III型胶原蛋白的这种九肽)沿着多聚化胶原纤维形成的刚性结构重复交错排列所致。